Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.40 |
| ▸ | MGLL | Q99685 | 3/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.39 |
| ▸ | CNR2 | P34972 | 3/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | GUSB | P08236 | 2/20 | 0.38 |
| ▸ | EBP | Q15125 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10563056 | 0.76 | — | — | |
| SCHEMBL25021979 | 0.73 | GBA1 (0.44) | GBA1ALDH1A1GNAI3GNAO1GNAI1 | |
| SCHEMBL27470145 | 0.70 | L3MBTL1 (0.38) | GBA1ALDH1A1GNAI3GNAO1GNAI1 | |
| SCHEMBL31093212 | 0.70 | GBA1 (0.47) | GBA1ALDH1A1GNAI3GNAO1GNAI1 | |
| SCHEMBL9769271 | 0.70 | GBA1 (0.47) | GBA1ALDH1A1GNAI3GNAO1GNAI1 | |
| SCHEMBL9769185 | 0.70 | GBA1 (0.47) | GBA1ALDH1A1GNAI3GNAO1GNAI1 | |
| SCHEMBL31093244 | 0.70 | GBA1 (0.47) | GBA1ALDH1A1GNAI3GNAO1GNAI1 | |
| SCHEMBL9617015 | 0.70 | GBA1 (0.47) | GBA1ALDH1A1GNAI3GNAO1GNAI1 | |
| SCHEMBL8295085 | 0.69 | GBA1 (0.48) | GBA1ALDH1A1PTGS1PTGS2MGLL | |
| SCHEMBL11603737 | 0.69 | GBA1 (0.48) | GBA1ALDH1A1PTGS1PTGS2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | GBA1 1269/4885ALDH1A1 2110/4885GNAI3 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.